In addition, distributing the patients on the basis of high and low RAGE levels (3Q of RAGE gene expression as threshold), we found that elevated EphA3 expression is predictive of a worse OS also in the BC subgroup of patients displaying high RAGE levels (Fig. 7E). This evidence concerns the gene EPHA3 and breast cancer.